Long-Term Exposure to Particulate Matter Increases CV Mortality Risk in COPD
In adults with COPD, long-term exposure to PM2.5 was associated with an increased risk for cardiovascular mortality.
Chronic Obstructive Pulmonary Disease
Indoor Mold Exposure, Anti-Aspergillus Antibodies May Hold Clinical Implications for COPD
Indoor mold exposure and the presence of anti-Aspergillus antibodies may be linked to worsened lung function during exacerbations in COPD.
ACA Improved Uninsurance Rates in COPD and Asthma, but Not Affordability
While the ACA effectively reversed coverage losses for patients with airway disease, neither care affordability nor disparities improved for these patients.
E-Cigarette Use May Increase COPD Risk
Electronic cigarette (e-cigarette) use may be associated with an increased risk of chronic obstructive pulmonary disease (COPD).
Effects of COVID-19 Lockdown in Spain on Patients With COPD
In patients with COPD, lockdown for coronavirus disease 2019 (COVID-19) was associated with a reduction in exacerbations and an improvement in symptoms.
Potential Beneficial Effects of Antidiabetic Medications on COPD Exacerbations
Duration-dependent beneficial effects of metformin, sulfonylurea, and thiazolidinedione use on COPD exacerbation have been observed in patients with COPD and diabetes.
Reduced All-Cause Mortality in COPD With Budesonide/ Glycopyrrolate/ Formoterol
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate may reduce the risk of death compared with glycopyrrolate/formoterol fumarate in patients with COPD.
Inhaled Corticosteroid Therapy May Reduce Lung Function Decline in COPD
The adjusted rate of decline in predose trough FEV1 during 52 weeks in the
Researchers used a substudy of the Phase 3 ETHOS study to evaluate lung function decline in patients with inhaled corticosteroid-containing therapies vs glycopyrrolate/formoterol fumarate metered dose inhaler.
Revefenacin Plus Formoterol Via Nebulization Improves Lung Function Response in COPD
Once-daily revefenacin when administered via a jet nebulizer with formoterol was well tolerated and associated with greater lung function response compared with formoterol alone in patients with COPD.
COVID-19 With COPD: Fewer Hospitalizations, But Greater Mortality
Chronic obstructive pulmonary disease may be associated with higher rates of mortality in patients with coronavirus disease 2019.
- Loading...
Loading...
Next post in Year in Review COPD 2020
Loading... 
Loading...